FDA Commissioner Marty Makary has appointed Tracy Beth Høeg, known for her critical stance on Covid-19 vaccines, as the acting director of the Center for Drug Evaluation and Research (CDER). This decision follows Høeg’s involvement in the investigation of Covid-19 vaccines, where her insights have sparked considerable debate within the pharmaceutical community.
Høeg’s appointment comes at a pivotal time for the FDA as it navigates ongoing scrutiny regarding vaccine safety and efficacy. Her background as a skeptic may influence the agency’s approach to drug approvals and regulatory oversight, particularly in the context of emerging therapies and public health initiatives. Industry stakeholders, especially those in regulatory, QA/QC, and CMC roles, will be closely monitoring how Høeg’s leadership could shape the future of drug evaluation processes and impact the overall landscape of pharmaceutical development.
Use the database as your supply chain compass →
